Protect your sleep routine
A maintenance dose after weight loss may be considered when: Youre at or near your goal weight Your provider feels that continued weight loss is no longer needed Some people stay on the same dose they reached during weight loss, while others move to a slightly lower dose that feels easier to maintain long term
Because of the unknown potential for serious adverse reactions in the breastfed infant due to the possible accumulation of SNAC, an absorption enhancer for RYBELSUS , and because there are alternative formulations of semaglutide that do not contain SNAC that can be used during lactation, advise patients that breastfeeding is not recommended during treatment with RYBELSUS Please click here for RYBELSUS Prescribing Information, including Boxed Warning
The key risks across both compounds include: Gastrointestinal adverse events (nausea, vomiting, diarrhoea), most pronounced during dose escalation Potential for gallbladder disease, consistent with rapid weight reduction Retatrutide-specific: dysesthesia and elevated resting heart rate [3] Both compounds: risk of hypoglycaemia when used in combination with insulin or sulphonylureas in diabetic models All compounds available through Sempica are strictly for research use by qualified professionals
Dose timing and exercise Exercise timing relative to tirzepatide injection is a common concern for people using the medication alongside fitness programs
Monitoring and Communication Keep a symptom diary noting bowel movement frequency, consistency, and any associated symptoms
